Skip to NavigationSkip to content

Pharmafile - Research and Development News

Novartis Holly Springs
Will spend $36m to set up research laboratory
Anticoagulant shows superiority over enoxaparin in late stage trial
Will bolster early stage pipeline in fibrotic diseases and oncology
Withdraws filing for prophylaxis of serious respiratory syncytial virus
Novartis' Swiss HQ
Worldwide regulatory filings of INC424 planned for 2011
Novo Nordisk HQ
Will collaborate with US biotech Emisphere Technologies
Says drug could improve the safety of long-term HIV treatment
Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches